United States

Anatara Lifesciences Ltd (ANR.AX)

ANR.AX on Australia Stock Exchange

24 May 2017
Change (% chg)

$-0.03 (-3.75%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Anatara Lifesciences says transition of Mel Bridges into a combined CEO / Chairman role
Sunday, 26 Jun 2016 06:26pm EDT 

Anatara Lifesciences Ltd : Says CEO, Paul Schober to retire and chairman, Mel Bridges to transition to chairman & CEO role .  Full Article

Anatara Lifesciences Ltd raises $7 million, launches share purchase plan to speed development of Detach
Thursday, 2 Jul 2015 08:27pm EDT 

Anatara Lifesciences Ltd:Says it has raised $7 million through significantly oversubscribed capital raising to fund international registration and further development of its lead therapy, Detach, a non-antibiotic, natural treatment to treat and prevent diarrhoea in pigs and other livestock animals.Says that Anatara has also announced share purchase plan that it will also offer each eligible shareholder opportunity to subscribe for up to $15,000 in Anatara shares.Says under capital raising, around 9 million fully paid ordinary shares will be issued at a price of $0.78 per share.Says funds raised will be used primarily to carry out parallel registration trials of Detach in Europe and United States.Says funds will also be used to ramp up manufacturing, safety studies, registration in Asia, proof of concept to use Detach in calves and poultry, and advance development of its use in humans.  Full Article

More From Around the Web